BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Biotech Support Group Release: SeraFILE™ Separations Platform for Functional Proteomic Profiling of Phosphodiesterases


12/3/2012 12:46:29 PM

Dec 01, 2012 - Monmouth Junction, NJ, - ProFACT Proteomics and its partner in research consumables, Biotech Support Group LLC, reports on a new journal article which describes the use of SeraFILE™, a proprietary protein separations platform. The article illustrates how SeraFILE™ is used to efficiently produce unique subproteomes, with resulting enzyme measurements integrated into molecular profiles. The results demonstrate that the proposed methods provide a means to simplify intersample differences, and to localize proteins attributable to sample-specific responses.

The citation is:

Functional Proteomic Profiling of Phosphodiesterases Using SeraFILE Separations Platform, International Journal of Proteomics, vol. 2012, Article ID 515372, 8 pages, 2012. doi:10.1155/2012/515372.

You may directly access this article at http://www.hindawi.com/journals/ijpro/2012/515372/

“This research demonstrates that our unique approach to functional proteomics can break down complex proteomes into subproteomes and by doing this, compartmentalize an enriched fraction associated with disease. Deeper LC-MS characterization of these fractions can help identify prospective biomarkers. Furthermore, the same approach can index the effects of drug modulation and we hope to further exploit these SeraFILE™ applications to create a bulls-eye effect for drug repurposing.” states Matthew Kuruc, President of ProFACT Proteomics.

For more information about SeraFILE PROspector™, click:

SeraFILE PROspector™ - Differentiated Subproteomes and Enrich Functional Biomarkers http://www.biotechsupportgroup.com/node/230

About Biotech Support Group LLC

Biotech Support Group LLC is a leading provider of genomics and proteomics sample preparation products and enrichment reagent kits as well as integrated biotechnology services for life sciences research, biomarker and drug discovery. Based in New Jersey, it’s principal products include: Albusorb™ for albumin depletion, AlbuVoid™ for albumin depletion plus low abundance serum protein enrichment, Cleanascite™ for lipid adsorption and clarification, NuGel™ for passivated silica-based affinity chromatography, and ProCipitate™ & ProPrep™ for nucleic acid isolation. Biotech Support Group is the leading developer of sample preparation products for separating and purifying hemoglobin from blood samples. HemoVoid™ is a hemoglobin depletion reagent kit from red blood cells and HemogloBind™ is a hemoglobin capture reagent from hemolyzed serum. Currently, Biotech Support Group LLC and ProFACT Proteomics Inc., are collaborating on the development of a proteomics platform used in functional profiling for proteomic analysis and a separations method for generating sub-proteomes used in biomarker and functional proteomic prospecting. For more information, go to: http://www.biotechsupportgroup.com/

About ProFACT Proteomics

ProFACT Proteomics, Inc. is a privately held early-stage corporation which applies its enabling proprietary Proteomics technology, for development of therapeutics, biomarkers and personalized medicine. Through partnership and service agreements, ProFACT participates in 4 related platform areas: SeraFILE™, for reduction of protein complexity and sub-proteome creation; Functional Proteome Prospecting™, to enrich and isolate functional activity; Conformerics™, to profile protein drug responsiveness from natural sources; and Rational Genome to Proteome Prospecting™, for prospecting into protein expression based on gene expression data. For more information, please visit http://www.profactproteomics.com.

CONTACTS:

Dr.Swapan Roy

Biotech Support Group

1 Deer Park Drive, Suite M,

Monmouth Junction, NJ 08852, USA

732-274-2866

sales@biotechsupportgroup.com

Matthew Kuruc

ProFACT Proteomics

732-230-3021

mkuruc@profactproteomics.com

http://www.profactproteomics.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES